Innovative Drug Development to Extend Lifespan of Large Dog Breeds

This chapter explores the efforts of a San Francisco biotech company, Loyal, in developing a life-extension drug for larger dog breeds to bridge the lifespan gap with smaller breeds. Positive feedback from the U.S. FDA has been received, showing promising results in lowering a specific hormone linked to dog size and aiming to enhance the dogs' longevity and well-being.